ММВБ 3 175 -1,1%  Nasdaq 9 384 0,1%  Биткойн 8 581 -1,0%  USD/RUB 61,9715 0,1% 
РТС 1 613 -1,3%  S&P500 3 322 0,0%  Нефть 62,4 -0,4%  EUR/RUB 68,6605 0,0% 
Dow 29 186 0,0%  FTSE100 7 572 -0,5%  EUR/USD 1,1087 -0,1% 

Курс акций Resmed [ISIN: AU000000RMD6]

купить
продать

Resmed Inc (CDI) on a ratio of 10 CDIs per ord.sh - Профиль

ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through the following segments: Sleep and Respiratory Care, and SaaS. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The SaaS segment engages in the supply of business management software as a service to out-of-hospital health providers. Its product portfolio includes devices, diagnostic products, mask systems, headgear and other accessories, and dental devices. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Акционеры

Название Доля (%)
Schroder Isf - Asian Total Return0,51

Адрес

9001 Spectrum Center Boulevard, 92123 San Diego
а/я:
Телефон: +1 (858) 836-5000
Факс:
Вэб: http://www.resmed.com

Менеджмент

Michael J. Farrell
Chief Executive Officer & Director
Brett A. Sandercock
Chief Financial Officer
Carlos M. Nunez
Chief Medical Officer
Nupur Bhushan
Chief People Officer
Hemanth Reddy
Chief Strategy Officer
Bobby Ghoshal
Chief Technology Officer
Harjit Gill
Director
Jan de Witte
Director
Amy Wakeham
Head-Investor Relations
Carol J. Burt
Independent Director
Karen Drexler
Independent Director
Richard Sulpizio
Independent Director
Ronald R. Taylor
Lead Independent Director
Peter C. Farrell
Non-Executive Chairman
Robert Andrew Douglas
President & Chief Operating Officer
Raj Sodhi
President-SaaS Business
James Hollingshead
President-Sleep Business
David Brian Pendarvis
Secretary, CAO & Global General Counsel
Geoff Neilson
Senior Vice President-Global Supplier Alliance

Добавить или редактировать инструмент